Mahtta D, Ramsey DJ, Lee MT, Chen L, et al. Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care 2022 Jan 6. pii: 139194. doi: 10.2337/dc21-1815.
PMID: 35015080